Style | Citing Format |
---|---|
MLA | Azadnajafabad S, et al.. "Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans." Journal of Diabetes and Metabolic Disorders, vol. , no. , 2021, pp. -. |
APA | Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, Rezaei N, Naderimagham S, Larijani B, Farzadfar F (2021). Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans. Journal of Diabetes and Metabolic Disorders, (), -. |
Chicago | Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, Rezaei N, Naderimagham S, Larijani B, Farzadfar F. "Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans." Journal of Diabetes and Metabolic Disorders , no. (2021): -. |
Harvard | Azadnajafabad S et al. (2021) 'Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans', Journal of Diabetes and Metabolic Disorders, (), pp. -. |
Vancouver | Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, et al.. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans. Journal of Diabetes and Metabolic Disorders. 2021;():-. |
BibTex | @article{ author = {Azadnajafabad S and Mohammadi E and Aminorroaya A and Fattahi N and Rezaei S and Haghshenas R and Rezaei N and Naderimagham S and Larijani B and Farzadfar F}, title = {Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Azadnajafabad S AU - Mohammadi E AU - Aminorroaya A AU - Fattahi N AU - Rezaei S AU - Haghshenas R AU - Rezaei N AU - Naderimagham S AU - Larijani B AU - Farzadfar F TI - Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans JO - Journal of Diabetes and Metabolic Disorders VL - IS - SP - EP - PY - 2021 ER - |